In the first half of April xxxx, Cyclohexanone prices were on a downtrend in key world markets such as the United States, Germany, and China. The price reduction was led by muted demand, firm to sufficient supply, and softer upstream prices. The downstream sector weakness in products like caprolactam and adipic acid also curbed buying interest, adding to the bearish sentiment.
In the United States, cyclohexanone prices declined because of weakening demand from primary industries and softening feedstock prices. Caprolactam and Adipic acid manufacturers kept raw material purchases to a bare minimum in the face of low fiber and auto demand. The decline in benzene and cyclohexane prices pulled down production costs, enabling producers to cut offers. Domestic factory expansion weakened with forward-purchasing discouraged by policy uncertainty and prospective tariffs. Suppliers experienced stiff competition and oversupply issues, prompting discounting measures to maintain offtakes. Thus, U.S. cyclohexanone prices...
